# Outset Medical, Inc.: filings

OM · Nasdaq · CIK 1484612 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/om.md) · [Financials](/companies/om/financials.md) · [Filings](/companies/om/filings.md) · [Insiders](/companies/om/insiders.md)

## Reports and events: 101 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 346, 144 115, 8-K 66, 3 27, SC 13G/A 25, 10-Q 18, SCHEDULE 13G/A 16, SC 13G 14, CORRESP 10, DEFA14A 9, SCHEDULE 13G 8, D 7, DEF 14A 7, S-8 7, 10-K 6, UPLOAD 6, 4/A 4, EFFECT 4, SD 4, 424B4 3, DRS 3, DRSLTR 3, S-1 3, 3/A 2, DRS/A 2, S-1MEF 2, 424B3 1, 8-A12B 1, CERT 1, D/A 1, PRE 14A 1, S-1/A 1, S-3 1, S-3/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-28 | 20:05 ET | [8-K](/filings/0001193125-26-374323.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-374323 |
| 2026-08-06 | 21:15 ET | [10-Q](/filings/0001193125-26-338432.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338432 |
| 2026-08-06 | 20:05 ET | [8-K](/filings/0001193125-26-337953.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-337953 |
| 2026-06-17 | 20:05 ET | [8-K](/filings/0001193125-26-274135.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-274135 |
| 2026-06-05 | 20:05 ET | [8-K](/filings/0001193125-26-259527.md) | 5.07 Shareholder vote results | 0001193125-26-259527 |
| 2026-05-29 | 20:05 ET | [8-K](/filings/0001193125-26-248237.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-248237 |
| 2026-05-07 | 21:30 ET | [10-Q](/filings/0001193125-26-212481.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212481 |
| 2026-05-07 | 20:16 ET | [8-K](/filings/0001193125-26-211980.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211980 |
| 2026-04-24 | 20:06 ET | [DEF 14A](/filings/0001193125-26-177150.md) | Proxy statement, period 2026-06-04 | 0001193125-26-177150 |
| 2026-02-13 | 21:01 ET | [10-K](/filings/0001193125-26-051278.md) | Annual report, period 2025-12-31 | 0001193125-26-051278 |
| 2026-02-11 | 21:15 ET | [8-K](/filings/0001193125-26-046588.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-046588 |
| 2026-01-27 | 14:10 ET | [8-K](/filings/0001193125-26-023428.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-023428 |
| 2026-01-12 | 13:31 ET | [8-K](/filings/0001193125-26-009865.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-009865 |
| 2025-11-10 | 22:00 ET | [10-Q](/filings/0001193125-25-274504.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274504 |
| 2025-11-10 | 21:05 ET | [8-K](/filings/0001193125-25-274193.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-274193 |
| 2025-08-07 | 21:54 ET | [10-Q](/filings/0000950170-25-104300.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104300 |
| 2025-08-06 | 20:15 ET | [8-K](/filings/0000950170-25-104054.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104054 |
| 2025-06-03 | 20:35 ET | [8-K](/filings/0000950170-25-081009.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-081009 |
| 2025-05-14 | 13:10 ET | [8-K](/filings/0000950170-25-070964.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-070964 |
| 2025-05-08 | 21:45 ET | [10-Q](/filings/0000950170-25-066003.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066003 |
| 2025-05-07 | 20:15 ET | [8-K](/filings/0000950170-25-065680.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065680 |
| 2025-04-11 | 20:43 ET | [DEF 14A](/filings/0000950170-25-053260.md) | Proxy statement, period 2025-06-02 | 0000950170-25-053260 |
| 2025-03-20 | 20:01 ET | [8-K](/filings/0001193125-25-058953.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-058953 |
| 2025-03-18 | 12:30 ET | [8-K](/filings/0001193125-25-056206.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-056206 |
| 2025-03-11 | 20:35 ET | [8-K](/filings/0001193125-25-051981.md) | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-051981 |
| 2025-03-06 | 21:05 ET | [8-K](/filings/0000950170-25-034593.md) | 5.07 Shareholder vote results | 0000950170-25-034593 |
| 2025-02-28 | 21:24 ET | [10-K](/filings/0000950170-25-030045.md) | Annual report, period 2024-12-31 | 0000950170-25-030045 |
| 2025-02-26 | 21:10 ET | [8-K](/filings/0001193125-25-036741.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-036741 |
| 2025-02-19 | 21:10 ET | [8-K](/filings/0000950170-25-023167.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-023167 |
| 2025-02-04 | 21:58 ET | [DEF 14A](/filings/0001140361-25-003034.md) | Proxy statement, period 2025-03-05 | 0001140361-25-003034 |
| 2025-01-24 | 22:17 ET | [8-K](/filings/0001140361-25-001915.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-25-001915 |
| 2025-01-08 | 21:37 ET | [8-K](/filings/0001193125-25-003545.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-003545 |
| 2025-01-06 | 14:36 ET | [8-K](/filings/0001193125-25-001911.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-001911 |
| 2024-11-07 | 22:50 ET | [10-Q](/filings/0000950170-24-122518.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122518 |
| 2024-11-06 | 21:00 ET | [8-K](/filings/0000950170-24-122229.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122229 |
| 2024-09-27 | 20:05 ET | [8-K](/filings/0000950170-24-109993.md) | 3.01 Delisting notice | 0000950170-24-109993 |
| 2024-08-16 | 12:30 ET | [8-K](/filings/0000950170-24-097816.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-097816 |
| 2024-08-08 | 22:06 ET | [10-Q](/filings/0000950170-24-093071.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093071 |
| 2024-08-07 | 20:10 ET | [8-K](/filings/0000950170-24-092780.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092780 |
| 2024-05-30 | 20:05 ET | [8-K](/filings/0000950170-24-066561.md) | 5.07 Shareholder vote results | 0000950170-24-066561 |
| 2024-05-09 | 22:00 ET | [10-Q](/filings/0000950170-24-055981.md) | Quarterly report, period 2024-03-31 | 0000950170-24-055981 |
| 2024-05-08 | 20:10 ET | [8-K](/filings/0000950170-24-055657.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-055657 |
| 2024-05-06 | 12:10 ET | [8-K](/filings/0000950170-24-053215.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-053215 |
| 2024-04-11 | 20:05 ET | [DEF 14A](/filings/0000950170-24-043692.md) | Proxy statement, period 2024-05-29 | 0000950170-24-043692 |
| 2024-03-13 | 20:15 ET | [8-K](/filings/0000950170-24-030779.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-030779 |
| 2024-02-21 | 22:15 ET | [10-K](/filings/0000950170-24-018093.md) | Annual report, period 2023-12-31 | 0000950170-24-018093 |
| 2024-02-21 | 21:10 ET | [8-K](/filings/0000950170-24-017922.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-017922 |
| 2024-01-08 | 13:40 ET | [8-K](/filings/0000950170-24-002731.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002731 |
| 2024-01-02 | 21:41 ET | [8-K](/filings/0000950170-24-000306.md) | 2.03 New direct financial obligation | 0000950170-24-000306 |
| 2023-12-11 | 21:00 ET | [8-K](/filings/0000950170-23-069380.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0000950170-23-069380 |

Page 1 of 3. [Older](/companies/om/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.